Abstract
The aim of our work was to study (1) the antioxidant properties of lipoic acid (LA) and its reduced metabolite dihydrolipoic acid (DHLA) formed by reduction of LA and (2) the effects of treatment with LA and DHLA on (a) K+ efflux from human red blood cells and (b) post-ischemic recovery and oxidative stress in isolated perfused rat hearts challenged with an ischemia-reperfusion (IR) sequence. In vitro, we used xanthine and xanthine oxidase to generate superoxide anion, which is not directly measurable by electron paramagnetic resonance (EPR), but specifically oxidizes the spin probe CPH into an EPR-detectable long lasting CP• nitroxide radical. While 5 mM of LA was ineffective in reducing the kinetics of CP• nitroxide formation, DHLA was shown to lessen this rate in a dose-dependent manner and at 30 mM was even more efficient than 300 UI/ml SOD. These results are in agreement with the fact that DHLA is able to directly scavenge superoxide anion. Red cells are a good model to investigate oxidative damage in biological membranes; hence, we used a suspension of erythrocytes incubated with 2,2′-azobis(2-amidinopropane) hydrochloride (AAPH) which generates in vitro free radicals. DHLA provided more effective protection of red cells membranes than LA; DHLA was comparable to Trolox for its antioxidant potency. In vivo, treatment of rats (50 mg/kg/day i.p. for 7 days) with LA induced a slight increase in coronary flow (CF) in isolated perfused hearts, after 30 min of global total ischemia. This effect was not associated with an improvement in contractile function and reduction of myocardial oxidative stress. In conclusion, because of their ability to scavenge free radicals, LA and to an even greater degree DHLA were able to protect the membranes of red blood cells. This finding suggests that LA and DHLA might be useful in the treatment of diseases associated with oxidative stress such as diabetes.
Similar content being viewed by others
References
Moini H, Packer L, Saris NE (2002) Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182:84–90. doi:10.1006/taap.2002.9437
Biewenga GP, Haenen GR, Bast A (1997) The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29:315–331. doi:10.1016/S0306-3623(96)00474-0
Bilska A, Wlodek L (2005) Lipoic acid—the drug of the future? Pharmacol Rep 57:570–577
Jones W, Li X, Qu ZC et al (2002) Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells. Free Radic Biol Med 33:83–93. doi:10.1016/S0891-5849(02)00862-6
Ziegler D, Hanefeld M, Ruhnau KJ et al (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22:1296–1301. doi:10.2337/diacare.22.8.1296
Packer L, Kraemer K, Rimbach G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888–895. doi:10.1016/S0899-9007(01)00658-X
Holmquist L, Stuchbury G, Berbaum K et al (2007) Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias. Pharmacol Ther 113:154–164. doi:10.1016/j.pharmthera.2006.07.001
Cakatay U (2006) Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid. Med Hypotheses 66:110–117. doi:10.1016/j.mehy.2005.07.020
Dhalla NS, Elmoselhi AB, Hata T et al (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47:446–456. doi:10.1016/S0008-6363(00)00078-X
Zweier JL, Talukder MA (2006) The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70:181–190. doi:10.1016/j.cardiores.2006.02.025
Levitsky S (2006) Protecting the myocardial cell during coronary revascularization. The William W. L. Glenn Lecture. Circulation 114:I339–I343. doi:10.1161/CIRCULATIONAHA.105.001685
Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255–266. doi:10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
Fortuno A, San Jose G, Moreno MU et al (2005) Oxidative stress and vascular remodelling. Exp Physiol 90:457–462. doi:10.1113/expphysiol.2005.030098
Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912–1916. doi:10.1161/01.CIR.0000093660.86242.BB
Marczin N, El-Habashi N, Hoare GS et al (2003) Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys 420:222–236. doi:10.1016/j.abb.2003.08.037
Kaminski KA, Bonda TA, Korecki J et al (2002) Oxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury. Int J Cardiol 86:41–59. doi:10.1016/S0167-5273(02)00189-4
Arivazhagan P, Juliet P, Panneerselvam C (2000) Effect of dl-alpha-lipoic acid on the status of lipid peroxidation and antioxidants in aged rats. Pharmacol Res 41:299–303. doi:10.1006/phrs.1999.0594
Becker LB (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461–470. doi:10.1016/j.cardiores.2003.10.025
Zhu QY, Schramm DD, Gross HB et al (2005) Influence of cocoa flavanols and procyanidins on free radical-induced human erythrocyte hemolysis. Clin Dev Immunol 12:27–34. doi:10.1080/17402520512331329514
Tavazzi B, Di Pierro D, Amorini AM et al (2000) Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress. Eur J Biochem 267:684–689. doi:10.1046/j.1432-1327.2000.01042.x
Cremer DR, Rabeler R, Roberts A et al (2006) Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol 46:29–41. doi:10.1016/j.yrtph.2006.06.004
Shiva Shankar Reddy CS, Subramanyam MV, Vani R et al (2007) In vitro models of oxidative stress in rat erythrocytes: effect of antioxidant supplements. Toxicol In Vitro 21:1355–1364. doi:10.1016/j.tiv.2007.06.010
Lahet JJ, Lenfant F, Courderot-Masuyer C et al (2007) Comparison of three methods for oxidative stress-induced potassium efflux measurement. Biomed Pharmacother 61:423–426. doi:10.1016/j.biopha.2007.05.008
Buonocore G, Groenendaal F (2007) Anti-oxidant strategies. Semin Fetal Neonatal Med 12:287–295. doi:10.1016/j.siny.2007.01.020
Marchioli R (1999) Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res 40:227–238. doi:10.1006/phrs.1999.0480
Colado Simao AN, Suzukawa AA, Casado MF et al (2006) Genistein abrogates pre-hemolytic and oxidative stress damage induced by 2, 2′-Azobis (Amidinopropane). Life Sci 78:1202–1210. doi:10.1016/j.lfs.2005.06.047
Sato Y, Kamo S, Takahashi T et al (1995) Mechanism of free radical-induced hemolysis of human erythrocytes: hemolysis by water-soluble radical initiator. Biochemistry 34:8940–8949. doi:10.1021/bi00028a002
Lenfant F, Lahet JJ, Courderot-Masuyer C et al (2004) Lidocaine has better antioxidant potential than ropivacaine and bupivacaine: in vitro comparison in a model of human erythrocytes submitted to an oxidative stress. Biomed Pharmacother 58:248–254. doi:10.1016/j.biopha.2003.12.013
Lahet JJ, Lenfant F, Courderot-Masuyer C et al (2003) In vivo and in vitro antioxidant properties of furosemide. Life Sci 73:1075–1082. doi:10.1016/S0024-3205(03)00382-5
Brigelius-Flohe R, Traber MG (1999) Vitamin E: function and metabolism. FASEB J 13:1145–1155
Traber MG, Atkinson J (2007) Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43:4–15. doi:10.1016/j.freeradbiomed.2007.03.024
Ko KM, Yiu HY (2001) Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Mol Cell Biochem 220:141–147. doi:10.1023/A:1010979404447
Coombes JS, Powers SK, Hamilton KL et al (2000) Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol 279:R2149–R2155
Coombes JS, Powers SK, Demirel HA et al (2000) Effect of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion. Acta Physiol Scand 169:261–269. doi:10.1046/j.1365-201x.2000.00740.x
Acknowledgments
This work was supported by grants from the Conseil Regional de Bourgogne, the Association de Cardiologie de Bourgogne, and the Agence Universitaire de la Francophonie. We would like to thank Philip Bastable for English proof reading.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghibu, S., Lauzier, B., Delemasure, S. et al. Antioxidant properties of alpha-lipoic acid: effects on red blood membrane permeability and adaptation of isolated rat heart to reversible ischemia. Mol Cell Biochem 320, 141–148 (2009). https://doi.org/10.1007/s11010-008-9916-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9916-0